Heartflow (HTFL) Net Margin (2024 - 2025)

Heartflow (HTFL) recorded quarterly Net Margin of 175.84% in Q4 2025, up 260.01% quarter-over-quarter from 109.89% in Q3 2025, and down 556.0% on a YoY basis from 38.56% in Q4 2024.

Heartflow (HTFL) Net Margin (2024 - 2025) Analysis & Trends

Heartflow's Net Margin history runs 2 years deep, the most recent figure standing at 175.84% for Q4 2025.

  • In Q4 2025, Net Margin fell 556.0% year-over-year to 175.84%; the TTM figure through Dec 2025 stood at 51.66% (changed N/A YoY), while the FY2025 annual figure was 66.35%, up 1030.0% from the prior year.
  • Net Margin was 175.84% for Q4 2025 at Heartflow, up from 109.89% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 181.4% in Q4 2024 to a low of 109.89% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn 29.55%
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn 2.06%
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn 19.57%
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn 18.66%
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn -8.93%
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn 13.15%
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn 13.80%
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn 0.61%
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn 3.68%
10 Heartflow 1.24 Bn 1.06 Bn 39.06 Mn 175.84%

Historic Data

Download Data
DateValue
Dec 31, 2025 175.84%
Sep 30, 2025 -109.89%
Jun 30, 2025 -21.18%
Dec 31, 2024 181.40%
Sep 30, 2024 -58.12%
Jun 30, 2024 -75.28%